Quick Answer
Cabaletta Bio, Inc. reported Operating Income of -$172.24 million for fiscal year 2025.
Cabaletta Bio, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$172.24M | -37.6% |
| 2024 | -$125.14M | -67.6% |
| 2023 | -$74.66M | -37.9% |
| 2022 | -$54.14M | -16.9% |
| 2021 | -$46.31M | -36.9% |
| 2020 | -$33.83M | -81.1% |
| 2019 | -$18.68M | -201.7% |
| 2018 | -$6.19M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$46.59M | -41.0% | -1.5% |
| June 30, 2025 | -$45.91M | -51.6% | -23.6% |
| March 31, 2025 | -$37.14M | -32.5% | -12.4% |
| September 30, 2024 | -$33.05M | -77.0% | -9.1% |
| June 30, 2024 | -$30.28M | -90.6% | -8.0% |
| March 31, 2024 | -$28.03M | -65.3% | -50.2% |
| September 30, 2023 | -$18.67M | -58.5% | -17.5% |
| June 30, 2023 | -$15.89M | -21.7% | +6.3% |
- Cabaletta Bio, Inc. showed a decrease of -37.6% in Operating Income compared to the prior fiscal year.
- Over the 2018–2025 period, Cabaletta Bio, Inc.’s operating income has declined by 2681.2% (from -$6.19 million to -$172.24 million).
- The most recent figure is from Cabaletta Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: